查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1944195

全球慢性骨盆疼痛治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Chronic Pelvic Pain Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 113 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計慢性骨盆疼痛治療市場規模將從 2025 年的 73.6 億美元成長到 2034 年的 106.7 億美元，2026 年至 2034 年的複合年成長率為 4.22%。

由於人們對慢性骨盆疼痛 (CPP) 及其對生活品質影響的認知不斷提高，慢性骨盆疼痛治療市場正經歷顯著成長。慢性骨盆腔疼痛可能由多種潛在疾病引起，例如子宮內膜異位症、骨盆腔發炎和間質性膀胱炎，因此亟需有效的治療方法方案。這些疾病盛行率的上升以及人們對女性健康的日益關注，正在推動對慢性骨盆疼痛治療解決方案的投資，進一步促進市場擴張。

技術進步在塑造慢性骨盆疼痛治療市場的未來方面發揮關鍵作用。微創手術技術、藥物和物理治療的創新正在改善慢性骨盆疼痛的治療。此外，遠端醫療和數位健康解決方案的整合正在提高醫療服務的可近性，並為患者提供個人化的治療方案。隨著製造商和醫療服務提供者不斷創新和開發新的解決方案，預計慢性骨盆疼痛治療市場將在各種醫療機構中得到更廣泛的應用。

此外，慢性骨盆疼痛管理中日益重視多學科協作也是推動市場成長的因素之一。隨著醫療服務提供者認知到慢性骨盆疼痛的複雜性，對兼顧生理和心理兩方面的綜合治療方案的需求也日益成長。這一趨勢促進了婦科醫生、疼痛管理專家和心理健康專家等各領域專家之間的合作，並推動了能夠改善患者預後的整合式診療路徑的建立。隨著市場的不斷發展，技術的融合、多學科協作以及以患者為中心的診療模式將成為市場成功的關鍵促進因素。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 繪製滲透率和成長前景圖
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

4. 全球慢性骨盆腔疼痛治療市場（依技術分類）

  • 市場分析、洞察與預測
  • 藥物（止痛藥、荷爾蒙療法、抗生素、抗憂鬱劑）
  • 手術（腹腔鏡手術、子宮切除術）
  • 其他

5. 全球慢性骨盆腔疼痛治療市場（依通路分類）

  • 市場分析、洞察與預測
  • 零售藥局和藥局
  • 電子商務
  • 其他

6. 全球慢性骨盆腔疼痛治療市場（按地區分類）

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商格局（基於現有資訊）
  • 策略規劃

第8章 公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • BayerAG
    • Becton
    • Dickinson And Company
    • GlaxoSmithKline Pic
    • Hospiinz
    • Intuitive Surgical
    • MAST PAK SURGICAL CORP
    • Mayne Pharma Group Limited
    • Medtronic
    • Perigo Company Pic
簡介目錄
Product Code: VMR11218700

The Chronic Pelvic Pain Treatment Market size is expected to reach USD 10.67 Billion in 2034 from USD 7.36 Billion (2025) growing at a CAGR of 4.22% during 2026-2034.

The Chronic Pelvic Pain Treatment Market is experiencing significant growth as the awareness of chronic pelvic pain (CPP) and its impact on quality of life increases. Chronic pelvic pain can result from various underlying conditions, including endometriosis, pelvic inflammatory disease, and interstitial cystitis, necessitating effective treatment options. The rising prevalence of these conditions and the growing focus on women's health are driving investments in chronic pelvic pain treatment solutions, further propelling market expansion.

Technological advancements are playing a crucial role in shaping the future of the chronic pelvic pain treatment market. Innovations in minimally invasive surgical techniques, pharmacological therapies, and physical therapy modalities are enhancing the management of chronic pelvic pain. Additionally, the integration of telemedicine and digital health solutions is improving access to care and enabling personalized treatment plans for patients. As manufacturers and healthcare providers continue to innovate and develop new solutions, the chronic pelvic pain treatment market is likely to see increased adoption across various healthcare settings.

Moreover, the growing emphasis on multidisciplinary approaches to chronic pelvic pain management is influencing the market's growth trajectory. As healthcare providers recognize the complexity of CPP, there is a rising demand for comprehensive treatment plans that address both physical and psychological aspects of the condition. This trend is driving collaboration between specialists, including gynecologists, pain management experts, and mental health professionals, to develop integrated care pathways that improve patient outcomes. As the market continues to evolve, the integration of technology, multidisciplinary care, and patient-centered approaches will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

  • Medications (Pain Relievers, Hormone Treatments, Antibiotics, Antidepressants)
  • Surgery (Laparoscopic Surgery, Hysterectomy)
  • Others

By Distribution Channel

  • Retail Pharmacies & Drug stores
  • E-commerce
  • Others

COMPANIES PROFILED

  • BayerAG, Becton, Dickinson and Company, GlaxoSmithKline pic, Hospiinz, Intuitive Surgical, MAST PAK SURGICAL CORP, Mayne Pharma Group Limited, Medtronic, Perigo Company pic

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CHRONIC PELVIC PAIN TREATMENT MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Technology
  • 4.2. Medications (Pain Relievers, Hormone Treatments, Antibiotics, Antidepressants) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Surgery (Laparoscopic Surgery, Hysterectomy) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CHRONIC PELVIC PAIN TREATMENT MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Distribution Channel
  • 5.2. Retail Pharmacies & Drug stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. E-commerce Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CHRONIC PELVIC PAIN TREATMENT MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Technology
    • 6.2.2 By Distribution Channel
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Technology
    • 6.3.2 By Distribution Channel
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Technology
    • 6.4.2 By Distribution Channel
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Technology
    • 6.5.2 By Distribution Channel
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Technology
    • 6.6.2 By Distribution Channel
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL CHRONIC PELVIC PAIN TREATMENT INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 BayerAG
    • 8.2.2 Becton
    • 8.2.3 Dickinson And Company
    • 8.2.4 GlaxoSmithKline Pic
    • 8.2.5 Hospiinz
    • 8.2.6 Intuitive Surgical
    • 8.2.7 MAST PAK SURGICAL CORP
    • 8.2.8 Mayne Pharma Group Limited
    • 8.2.9 Medtronic
    • 8.2.10 Perigo Company Pic